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The transition metal(II) chelates have been prepared by the reactions of bis-Schiff base ligands derived from 4-hydroxy 
benzohydrazide and isophthalaldehyde/ o-phthaldehyde in 1:1 metal to ligand ratio. The formed ligands and their metal 
complexes have been investigated by elemental analysis, different spectroscopic and thermal analyses techniques. The low 
molar conductance values give the non-electrolytic nature of the metal(II) chelates. From the spectroscopic observations of 
complexes, the molecular formula is found to be [M(Ln)2Cl2] (where M= Co(II), Ni(II), Cu(II) and Zn(II), n=1 and 2) and 
the tetradentate N2O2 donor sites of ligands is attached to the metal centre. The docking results predicts that the protein with 
ligands have good interaction energy. All formed complexes have efficient antibacterial activity than ligand for tested 
pathogens. The mode of binding interaction of ct-DNA and Cu(II) complexes gives the intercalative binding with 
hypochromism shifts using electronic titrations method. In electrophoresis, cleavages of PUC18DNA to cleave effectively 
with Cu(II) complexes in the presence of hydroxyl radicals. The antioxidant assay of DPPH radical scavenging activity of 
tested compounds shows good results, when compared to ascorbic acid as standard. The anticancer MTT assay of Cu(II) 
complexes tested against MCF-7 cancerous cells gives the promising therapeutic activity. 
Keywords: Bis-Schiff base, Docking, DNA binding and cleavage, Antioxidant, Anticancer activity 
Forthcoming days, cancer is a crucial problem in 
human health and causes a huge financial expense 
throughout the world. The world health organisation 
calculates that twelve million deaths worldwide will 
be due to cancer by 2030
1
. Metal based like cisplatin 
anticancer drug plays a leading role in the treatment 
of various malignant tumors, but serve as various side 
effects. Therefore, our aim is to prepare the 
chemotherapeutic drugs without side effects or fewer 
side effects
2
. This problem of cisplatin originates due 
to binding mode of covalent cross-links with DNA
3
. 
These disadvantages have motivated the chemists to 
develop novel metal compounds with improved 




Drug isomerism in research field has opened a new 
era of drug development. Currently, the knowledge of 
isomeric complexes has helped us to introducing the 
more efficient drug alternatives of the newer as well 
as existing drug
6
. Generally, the small molecules can 
react with DNA via covalent or non-covalent 
interactions. There are several types of sites in the 
DNA molecules where such binding can occur like (i) 
between two base pairs (intercalation), (ii) in the 




Metal complexes derived from hydrazine Schiff 
base are exhibiting an efficient of DNA syntheses by 
binding via intercalation mode
7
. The formation of 
intercalation mode which is favoured by the planarity 
of complexes due to interaction between planar 
aromatic ring and base pairs of DNA
8,9
, besides than 
other factors like size, nature of ligand, 
hydrophobicity, electron density of interacting 
aromatic rings and the geometry of complex, all 
played important roles
10
. Literatures reveal that Schiff 
base complexes of hydrazone exhibited such type of 
interactions; play an essential role as enzyme 
inhibitor, anticancer and antioxidants
11
. This 
intercalation is the main purpose of studying towards 
the design and development of new effective drugs. In 
recent days, the chemistry of hydrazone derivative 
ligand has gained much attention because of their 
structures with more than two donors presented in 




their relative positions which may serve as multi-
coordination sites and form stable chelates with 
essential metal ions
12,13
. Moreover, hydrazone exhibit 
a vital role in enhancing the selectivity and lethality 
profile of certain drug candidates. A vast content of 
literature is present on hydrazone type ligands 
unfolding their fascinating properties
14
 and also, a 
variety of polydentate chelates of these ligands have 
been reported to possess different co-ordination 
behaviour with different metal atoms
15
. The 
hydrazones are important class of Schiff base ligands, 
which have attracted attention of medicinal chemists 
due to their wide ranging biological and 
pharmaceutical properties such as anticancer, 
antimicrobial, antiviral and herbicidal properties
4,16
. 
Recent researches, there is an increasing interest in 
design and preparation of bis-hydrazones alongside 
with their metal complexes because of their chemical 
applications in biological fields
17
.  
Based on this background, in the study the novel 
monometallic complexes derived from 4-hydroxy-
benzohydrazide with isomers of isophthalaldehyde/ 
o-phthaldehyde were synthesised and characterised by 
elemental, molar conductance, UV, FT-IR, 
1
H NMR, 
ESR, ESI-MS, magnetic measurement and thermal 
studies. The synthesised bis-Schiff base hydrazone 
ligands and its metal complexes were successfully 
tested for docking, in vitro antibacterial, antioxidant, 
DNA cleavage properties. DNA binding and in vitro 
anticancer activity of human breast cancer MCF-7 cell 
line was also tested for the synthesised Schiff base 
Cu(II) complexes.  
 
Materials and Methods 
The analytical grade chemicals and reagents are 
used for this work are 4-hydroxybenzohydrazide 
(≥97% Merck), isopthaladehyde (98%, LOBA 
Chemie), o-phthalaldehyde (97.5%, Merck), hydrated 
metal chlorides (CoCl2.6H2O, NiCl2.6H2O, 
CuCl2.2H2O, ZnCl2.H2O), methanol (98%, Merck) 
and hydrochloric acid (AR grade). All chemicals were 
used for without further purification. 
 
Synthesis of bis-Schiff base ligands (1 & 2) 
The Schiff base ligands were prepared by the 
mixture of isophthaladehyde 1/ o-phthaldehyde 2 
(0.01 mol) and 4-hydroxybenzohydrazide (0.02 mol) 
in 1:2 molar ratio was stirred in 20 mL methanol 
followed by 5-6 drops of conc. HCl added
18
 and the 
mixture was refluxed at 60 °C for 4 h. The resulting 
coloured solution was kept in room temperature; the 
obtained precipitate was filtered, washed with 
methanol and dried under vacuum. 
 
Synthesis of metal complexes 
To a 20 mL of methanolic solution ligand (0.01 
mol) with metal chlorides (0.01 mol) like cobalt(II) 
chloride hexahydrate (CoCl2.6H2O)/ nickel(II) 
chloride hexahydrate (NiCl2.6H2O)/ copper(II) 
chloride dihydrate (CuCl2.2H2O)/ anhydrous zinc(II) 
chloride (ZnCl2) were separately stirred in 1:1 molar 
ratio and the reaction mixtures was refluxed for 4 h at 
70 °C
19
. The obtained coloured precipitate was 
filtered, washed with methanol followed by diethyl 
ether, dried under vacuum (Scheme 1). 
 
Instrumentation 
The following instrument techniques were used to 
characterise the synthesised Schiff base ligand and 
their complexes. The functional groups are presenting 
in the compounds were investigated on SHIMADZU 
model FT-IR spectrometer and the percentages of 
elements like C, H and N were determined on Flash 
1112 series elemental analyzer. The molecular masses 
of ligand complexes were measured by positive mode 
of Q-TOF ESI-Mass spectrometer. The magnetic 
moment values of unpaired electrons were calculated 
by Gouy’s balance using a callibrant Hg[Co(SCN)4]. 
In ligands, the chemical environment of protons was 
recorded on Bruker Advance 
1
H NMR (300 MHz) 
spectrometer. The absorbance of compounds was 
noted on Perkin Elmer Lambda spectrometer in the 
range of 800-200 nm. For finding the number of 
unpaired electron of complex the study was 
performed by using JES-FA200 ESR spectrometer at 
room temperature used as standard 
tetracyanoethylene. Thermal studies were performed 
with DSC-TGA Universal 4.5A instrument the range 
of 30-800 °C at heating rate 20 °C in atmospheric air. 
AutoDock 4.2.2 package was used for docking 
calculations and the protein structure of 
Staphylococcus aureus (PDB 1D: 2DHN) was 
downloaded from protein data bank. 
 
Testing procedure for antibacterial activity 
The antibacterial activities were employed by disc 
diffusion method and the all synthesised compounds 
were tested against pathogens of gram positive 
bacteria: Staphylococcus aureus and Bacillus subtilis 
strains, gram negative bacteria: Klebsiella 
pneumoniea and Escherichia coli strains. The nutrient 
agar medium was dispersed homogenously after mixed 




with distilled water. The whole medium was shifted to 
the Petri-plates, where the filter paper was placed on 
disc. 100 µL of sample was poured on separately and 
incubated at 37 °C for 24 h. A clear inhibition of zone 
was occurred in the circle form and was measured by 
diameter in nm. Zone of inhibition was compared with 




DNA interaction study 
The absorption titration experiments of DNA 
interaction of Cu(II) complex was performed in  
UV-visible absorption spectrometer using calf thymus 
(ct) DNA. The stock solution of ct-DNA was prepared 
by dissolving it in Tris-HCl/NaCl solution (5 Mm Tris 
HCl/50 Mm NaCl, pH 7.5) at different concentration. 
The ct-DNA concentration was determined by 
measuring the absorption intensity 265 nm with molar 
absorption co-efficient ( ) of 6600 M-1 cm-1. The stock 
solution of Cu(II) complex was made with  
10% methanol and 90% buffer (Tris-HCl/NaCl,  
ct-DNA) solution in constant concentration  
(100, 120,140, 160, 180 µM). The absorption of  
Cu(II) complex was carried out by the absence and 
presence of ct-DNA. The absorption titration was 
measured by successive increasing DNA concentration. 
In order to eliminate the absorption of DNA itself,  






Scheme 1 ― Structure of synthesised ligand 1, 2 and their metal complexes 




DNA cleavage study 
The studies of supercoiled plasmid PUC18DNA 
cleavage was performed by the synthesised ligands 
and their metal(II) complexes using agarose gel 
electrophoresis method. The reaction mixture 
containing 20 µL of PUC18DNA in 50 mM,  
Tris-HCl, pH 7.4, 52 mM, NaCl, 10 mM of H2O2 
were added in a different volume and then adding the 
millipore water for final volume. The mixed solutions 
were incubated at 37 °C for 1 h. After adding  
0.5 g powdered agarose to 50 mL of buffer solution, it 
is heated, then cooled and added to ethidium bromide. 






The antioxidant assay of all synthesised 
compounds were investigated by using 2,2’-diphenyl-
2-picrylhydrazyl radical (DPPH) scavenging method. 
The tested compounds were dissolved in DMSO and 
DPPH (50 µL, 0.6 mM) in methanol solution. The 
reaction mixture was prepared at various 
concentrations (10, 20, 30, 40, 50 μL). The solutions 
were incubated at room temperature for 20 min in 
dark place and read the absorbance at 517 nm. DPPH 
used as a blank solution as well in varying 
concentrations
23
. The percentage inhibitory of DPPH 
scavenging was calculated by the following equation. 
 
Percentage of inhibition = [(A0-A1)/A0] ×100 
 
Where, A0 is the absorbance of the control and A1 is 
the absorbance of the sample. The IC50 (concentration 
of sample required to scavenge 50% free radical or to 
prevent lipid peroxidation by 50%) was calculated 
from the regression equation. 
 
MTT assay of cytotoxicity 
In vitro cytotoxicity MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] assay of 
Cu(II) complexes were determined by using human 
MCF-7 cell line at 24 h of drug administration in 
different concentration. The stock solution of tested 
complexes were prepared from 1% DMSO diluted 
with medium. The monolayer cell line was cultured in 
96 well microtiter flat plate in DMEM medium 
supplemented with 10% inactivated Fetal Bovine 
Serum (FBS), Penicillin (100 units/mL) and 
Streptomycin (100 µg/mL) in a humidified at 37 ºC, 
5% CO2 atmosphere incubated for 24 h. The 
incubation was continued for 24 h when adding the 
tested complexes in various dilutions and cell counts 
was adjusted to 1     cell/mL and suspended on the 
plate. To find out the viability cells, spread solution of 
0.2% Trypsin, 0.02% EDTA and 0.05% glucose in 
PBS were added when adding with tested complexes. 
The absorbance was recorded by Shimadzu UV- 
visible spectrometer at 570 nm region of wavelength. 
Average values and percentage ratio were calculated 
through three times of independent experiments
24
. By 
non-linear regression equation gives the maximum 
inhibition concentration IC50 values on dose-
dependent manner.  
 
Results and Discussion 
The synthesised ligands N,N’-1,2-phenylenebis 
(methylidene))bis(4-hydroxybenzohydrazide) 1 and N, 
N’-1,3-phenylenebis (methylidene))bis(4-hydroxybenzo 
hydrazide) 2 with their complexes are coloured and 
stable in air at room temperature. The elemental 
analytical data (Table 1) reveals that the metal 
complexes co-ordinates with ligand in 1:1 molar ratio. 
The molar conductance values of 10
-3
 M concentration 
in DMF solution are obtained in range  
7.5-18.4            . These values indicate that the 
non-electrolytic nature of the metal complexes
25
.  
The infrared spectral data furnished the 
characteristic vibration modes and functionality of 
different groups of ligands and their complexes were 
synthesised. The infrared spectrum gave the valuable 
intensity regions are listed in Table 2 (Supplementary 
Data, Fig. S1 and S2). The characteristic sharp 
absorption bands of free ligand 1 appear at 1546 cm
-1
 
and ligand 2 appear at 1582 cm
-1
 due to stretching 
vibrations of azomethine (CH=N) group
26
. For 
complexes the absorbance bands are shifted to longer 
wavelength at 54-60 and 12-24 cm
-1
, likely to be  
co-ordination of metal ions with sharing of lone pair 
electrons of azomethine nitrogen atom. The ligands 
(C=O) stretching vibrations of medium bands displays 
at 1671 and 1662 cm
-1
. For complexes, these bands 
are highly shifted to their wavelength 65-35 and  
77-10 cm
-1
 which denotes the participation of  
co-ordination of metal ions with oxygen donor of 
carbonyl group. 
In lower frequencies, the complexes exhibit two 
small intensity bands in range of (M-O) and (M-N) 
stretching vibrations, while M-O stretching 
absorbance bands exhibited at 553-485 cm
-1
 and M-N 
stretching band appeared at 452-422 cm
-1
. The ligands 
1 and 2 exhibited the broad band of intensity in the 




region at 3318 and 3371 cm
-1
 for stretching vibration 
of OH and another band appeared at 3174 and  
3078 cm
-1
 for NH stretching vibration
27
. These bands  
are slightly changed for all formed complexes; 
indicate the non-involvement of co-ordination  
with metal ions and shows free manner of OH  
and NH groups.  
The proton nuclear magnetic resonance spectrum 
of ligands 1 and 2 gave the characteristic singlet 
signal of CH=N group found to be at   8.54-8.49 ppm 
as shown in Fig. 1. In downfield shifts of the two 
sharp singlet signals appeared at   10.45-10.16 ppm 
and   11.79-11.47 ppm due to presence of hydroxyl 
and NH protons. The multiplet signals of aromatic 
phenyl protons appeared at   7.8-7.5 ppm and    
6.82-6.90 ppm of chemical shifts
28
. This signal of 
peaks shows the purity of ligands. 
The mass spectra gave the promising results and 
used for elucidate the molecular structures of ligands 
and its metal complexes as shown in Fig. 2 and  
in Supplementary Data, Fig. S3 and S4. The  
ligand 1 exhibited the molecular ion peak M
+
 at  
m/z = 403.14 amu due to [M+1]
+
 and its complexes 









. Also ligand 2 exhibited the 
molecular ion peak M
+
 at m/z = 403.14 amu and its 










various fragmentations indicate the stability of the 
complexes and moreover, the obtained results are  
good agreement with the proposed structure of 
molecular formulae. 
The electronic spectra of ligands and its complexes 
values are listed in Table 3. The ligand 1 shows that 
Table 1 ― Elemental analytical data of ligand 1, 2 and their complexes 
Molecular formula Molecular 
weight 
Colour Melting  
point (    
Elemental analysis calculated (found) % Conductivity 
(            ) C H N 
C22H18N4O4 
[L1] 1 
402 Sandal 185 65.66 
(64.90) 
4.51 (4.31) 13.92 (13.34) - 
C22H18N4O4 
[L2] 2 
402 White 192 65.66 
(64.65) 
4.51 (4.46) 13.92 (13.74) - 
CoC22H18N4O4Cl2 
[CoL1Cl2] 1a 





278 49.65 (49.23) 3.41 (3.52) 10.53 (10.01) 7.5 
CuC22H18N4O4Cl2 
[CuL1Cl2] 1c 
536 Green 301 49.20 (48.54) 3.38 (3.91) 10.44 (9.86) 17.5 
ZnC22H18N4O4Cl2 
[ZnL1Cl2] 1d 
538 White 265 49.03 (49.25) 3.37 (3.18) 10.40 (9.65) 11.0 
CoC22H18N4O4Cl2 
[CoL2Cl2] 2a 





287 49.65 (49.01) 3.41 (3.61) 10.53 (10.71) 9.6 
CuC22H18N4O4Cl2 
[CoL2Cl2] 2c 
536 Green 312 49.20 (48.81) 3.38 (2.91) 10.44 (10.54) 18.4 
ZnC22H18N4O4Cl2 
[ZnL2Cl2] 2d 
538 Ash white 275 49.03 (47.59) 3.37 (3.43) 10.40 (9.91) 10.3 
 
Table 2 ― IR spectral values of ligands 1, 2 and their complexes 
Compound (OH) (NH) (C=O) (CH=N) (M-O) (M-N) 
1 3318 3174 1671 1546 - - 
2 3371 3078 1662 1582 - - 
1a 3264 2922 1689 1602 495 431 
1b 3244 2961 1724 1605 550 452 
1c 3217 2983 1680 1600 496 422 
1d 3309 2924 1736 1606 554 452 
2a 3243 3174 1657 1606 492 430 
2b 3252 3173 1652 1603 485 447 
2c 3261 3169 1739 1604 546 423 
2d 3280 3176 1672 1594 553 429 




the two absorption bands at 298, 317 nm and ligand 2 
shows bands at 281, 306 nm corresponding to π  π* 
and n π* transitions, respectively. The charge 
transfer band of all complexes appears at 432-362 nm 
indicates ligands co-ordinated to metal ions. The 
absorption spectrum of complexes 1a and 2a display 
the characteristics intensity bands at 608, 675 nm and 
608, 674 nm, which are assigned to 
3
A2g (F)   
3
T2g 
(F) ( 1), 
3
A2g (F)   
3
T1g (F) ( 2) and 
3
A2g (F)   
3
T1g 
(P) ( 3) transitions, respectively.  
The magnetic momentum of both complexes lie at 
3.62 BM and 3.53 BM, which confirmed the 
octahedral environment around the Co(II) ion
29,30
. The 
complex 1b gave the characteristic bands at 452,  
562 nm, and 2b complex gave the bands at 452, 608 
nm which attributed to transition of 
3





A1g (F)   
3
T2g (F), respectively, and the 
magnetic moment values fall on the range at 3.24 BM 
and 3.21 BM suggested that the octahedral structure 
of the both Ni(II) ion
31
. The intensity bands shows at 
432 nm for the complex 1c while the complex 2c gave 
the bands at 438, 538 nm assigned to 
2
Eg   
2




A1g transitions, respectively, and the magnetic 
moment 1.91 BM and 1.89 BM values reported the 
distorted octahedral geometry due to ligand field and 
Jahn-Teller effects
32,33
. The diamagnetic nature and 
the empirical formulae of formed complexes 1d and 
 
 
Fig. 1 ― 1H NMR spectra of ligand (a) 1 and (b) 2 
 
 
Fig. 2 ― Mass spectra of ligand (a) 1 and (b) 2 




2d proposed the octahedral arrangement around the 
Zn(II) ion.  
The X-band ESR spectra of the complexes 1c and 
2c were recorded in polycrystalline state at room 
temperature under the magnetic field (G) shown in 
Fig. 3. The ESR spectra of complex 2c gave the 
isotropic signal with no hyperfine splitting and the 
parameters of g‖‖, g┴ and ge (2.0023) values are listed 
in Supplementary Data, Table S1. In results, g‖‖ >g┴ 
suggested that the axially elongated octahedral, and 
an unpaired electron of    configuration 
predominantly present in dx2-y2 orbital. Meanwhile the 
complex 1c shows the super hyperfine structure split 
into three lines due to the ligand N strongly binds to 
metal atom and form Cu-N bond. This shows that the 






 expression (G) = (g‖‖-2)/ 
(g┴-2) gives the coupling interaction between the two 
Cu(II) ion. When G < 4.0, indicates to there is no 
coupling interaction between the presenting Cu(II) 
ion. The ESR result of (1c, 2c) shows that g‖‖ > 2.3 
indicating the complexes are covalent in nature
36
. 
The thermal stabilities of complexes were studied 
using TG and DSC analysis at heating rate of 20 
ºC/min in air. The representative TG-DSC curves of 
complexes are shown in Fig. 4. The thermal 
decomposition of 1a occurs in two steps. The first 
thermal degradation occurred between 64-177 °C 
followed by an endothermic DSC peak observed  
in 79 °C. This observed mass loss was attributed to 
the loss of chloride ions. The second stage of  
thermal degradation in 367 °C corresponds to 
decomposition of ligand from metal chelates. The 
thermal degradation of complex 2c occurred between 
in 112-232 ºC and followed by DSC peak observed  
in 104 ºC. This observed mass loss was attributed to 
the loss of chloride ions. The further second stage 
degradation occurs in 301 °C corresponds to 
decomposition of ligand from metal complex. Inspite 
of that, observed horizontal lines in the TGA curves 
of beyond 549 °C and 525 °C of the complex 1a, 2c 
indicates no further weight loss, implying that metal 
Table 3 ― Electronic spectra and magnetic data of ligand 1, 2 and their complexes 
Compounds Electronic spectra (nm) Transitions Geometry Magnetic 
moments π→π* n→π* L→M d-d 
1 298 317 - - - - - 
2 281 306 - - - - - 
1a 296 
 
318 402 608 675 3A2g (F)  3T2g (F) 3A2g 
(F)  3T1g (F) 
3A2g (F)  3T1g (P) 
Octahedral 3.62 
1b 308 347 371 452 562 3A1g (F)  3T1g (P)  3A1g 
(F)  3T2g (F) 
Octahedral 3.24 
1c 302 321 341 432 
 
2B1g  2A1g Distorted 
octahedral 
1.91 
1d 294 342 432 - - Octahedral - 
2a 281 370 379 608 674 3A2g (F)  3T2g (F) 3A2g 
(F)  3T1g (F) 
3A2g (F)  3T1g (P) 
Octahedral 3.53 
2b 290 371 389 452 708 3A1g (F)  3T1g (P)  3A1g 
(F)  3T2g (F) 
Octahedral 3.21 
2c 284 300 362 438 548 2Eg  2T2g 




2d 287 302 370 - - Octahedral - 
 
 
Fig. 3 ― Electron spin resonance spectra of complex (a) 1c and 
(b) 2c 




oxides may be final residue. Similar types of results 
are obtained for other complexes; the thermal  




Molecular docking is preeminent technique in 
structure based drug design to understand mechanism 
of ligand recognition and specific and thereby giving 
an insight into presumable protein-ligand interactions 
and binding affinity. Affinity of molecules to 
antibacterial receptors is very important in drug 
design. Therefore we carried out molecular docking 
of ligands with target protein (PDB ID: 2DHN). The 
molecular interactions of ligands for inhibition against 
Staphylococcus aureus protein represented in Fig. 5. 
According to this interaction, the ligand (1, 2) shows 
interactions with the active site residues (THR51, 
 
 




Fig. 5 ― Pictorial representation of possible binding sites of ligands (a) 1 and (b) 2 




ARG90, ASN82, ASN85 & GLU78, ASN120, 
ASV121) and the obtained inhibition energy  
was -22.32, -18.81 kcal/mol. This more negative 
value of estimated free energy of binding represents  
more efficient binding of ligands with  
target protein. 
 
In vitro antibacterial study 
The antimicrobial activities of all formed 
complexes were tested against pathogens of  
S. aureus, B. substilis, K. pneumoniea and  
E. coli bacterial strains
37
. All tested metal 
complexes having higher potential activity than the 
free Schiff base ligands (Table 4). As compared to 
all screened bacterial strains, the strain of E. coli 
showed better activity. The complexes 1c, 2a and 
2c gave efficient activity with tested pathogens than 
other complexes. The poor activity was showed by 
the complexes 1a and 2b. This was an explained on 
basis of chelation theory. It concludes that the 
antimicrobial activity was enhanced by 
complexation. In metal chelates, the polarity of 
central metal is decreased because partial sharing of 
its positive charge with associated donor groups of 
ligand and chelation enhances an electron 
delocalization over the whole chelating ring. It 
could be facilitate ability of the complexes to cross 
a lipid membrane of pathogens and form the 
hydrogen bonds with the imine groups of the active 
sites. This formation damages the cell membrane 




In vitro antioxidant activity 
The antioxidant of all synthesised compounds were 
tested by using 1,1’-diphenyl-1-picrylhydrazyl 
(DPPH) radical assay. The DPPH assay is widely 
used to determine the antioxidant capacity of bio-
metal compounds. DPPH radical is stable in normal 
conditions, but it combined with complexes donate an 
electron leads to destruction of the radical. All 
complexes show good inhibition activity than ligands 
when compared to standard. IC50 values of (1, 2, 1a-
2d) compounds and ascorbic acid are 40.99, 40.01, 
34.00, 22.41, 27.88, 39.90, 35.69, 24.52, 23.21, 38.21 
and 57.68 µg/mL. Commonly, the lower value of IC50 
indicates the higher antiradical capacity and the 
complexes 1c and 2c has high potential antioxidant 




UV-visible absorbance binding study 
The complexes (1c, 2c) were monitored by the 
binding mode of interaction with ct-DNA using UV-
visible absorbance titrations study. The binding ability 
of complexes in the absence and presence of ct-DNA 
was shown in Fig. 6. The absorbance gave the intense 
band at 259 nm for complex 1c and band at 260 nm 
for 2c assigned to be π  π* transition of aromatic 
chromophore
40
. In general, in ligands, the aromatic 
moieties are bind with DNA, through a intercalation 
Table 4 ― Antibacterial activities of synthesised ligands and  
their complexes 
Compounds Zone of inhibition in 100µg/mL (nm) 
Gram positive bacteria Gram negative bacteria 
S. aureus B. subtilis K. pneumoniea E. coli 
1 - - - - 
2 - - - - 
1a 6 8 6 3 
1b 8 9 8 7 
1c 9 10 11 8 
1d 9 10 9 8 
2a 10 12 10 9 
2b 5 8 5 7 
2c 12 13 12 10 
2d 8 12 10 7 
Tetracycline 15 14 17 10 
 
 
Fig. 6 ― UV-visible titrations of (a) 1c and (b) 2c in the absence and presence of 100, 120, 140, 160 and 180 µM of ct-DNA 
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binding which results to give hypochromism with red 
shift and azomethine group damage the double helix 
of DNA, which results in hyperchromism. It exhibits 
the strong π  π* stacking interaction between the 
aromatic chromophore ligand of metal complex and 
the base pairs of DNA. Addition of DNA with both 
complexes in increasing concentration (120, 140, 160, 
180, 200 µM) the bands are shifted to red 
approximately to 3, 5, 7, 9, 11 nm, respectively. These 
changes of complexes suggest that the binding 
interaction of complexes with DNA might to be 
intercalative mode 
41
 of hypocromism with red shifts. 
Electrophoresis of DNA cleavage activity 
The efficiency of all synthesised compounds to 
cleavage DNA was performed by gel electrophoresis 
using compact supercoiled plasmid PUC18DNA in 
ammonium acetate buffer at pH 7.5. Compact plasmid 
DNA was subjected through the gel electrophoresis, 
the fastest moving will be observed for supercoiled 
Form I (SC). If one strand of supercoil is cleaved, it 
will generates slow moving nicked Form II (NC) and 
both strands are cleaved, it will be converted to linear 
Form III (L) moves in between Form I and Form II
42
. 
Cleavages of PUC18DNA with increasing 
concentration of metal complexes in the presence of 
hydrogen peroxides are shown in the Fig. 7. 
During electrophoresis the plasmid DNA is not 
affected when the successive addition of complex 2a. 
Meanwhile, the tested compounds break DNA 
molecule in the presence of peroxide, due to 
formation of hydroxyl (
•
OH) radicals. These free 
radicals induces the pair of redox reactions between 
the partially reduces peroxide and the metal 
compounds and also participate in the oxidation of 
deoxyribose moiety, followed by hydrolytic cleavage 
of the sugar phosphate backbone
43,44
. The ligands 
(1, 2) and the complexes (1a, 1b, 1d, 2a, 2b, 2d) with 
supercoil PUC18DNA, gel electrophoresis migrates 
faster to produce Form I (SC) and then converted to 
Form II (NC). Eventhough, the complexes (1c, 2b) 
cleave both strands of DNA successfully to form III 
(L) with slow migration between SC and NC. The
efficient cleavage reduces the formation of





The cytotoxicity of complexes 1c and 2c of MCF-7 
cell line revealed that the IC50 values of 36.88 µM and 
57.56 µM shown in the Table 5 (Fig. 8). The lower 
inhibitory value of IC50 exhibits higher toxicity of 
complexes. The obtained inhibitory values are 
compared with the other studies, found to mostly 
greater cytotoxic effects towards the human MCF-7 
cell line
46,47
. This anticancer activity of complexes 
may be attributed to planarity and the enhancement of 
coordination of Cu(II) ion around the aromatic ring 
system and position of azomethine group. During the 
coordination of the complexes, positive charge of 
metal(II) ion increases due to donor group of 
ligands
48
. This leads to enhance the higher anticancer 
activity against MCF-7 cells.
Fig. 7 ― Oxidative DNA cleavages of ligands and its complexes 
in presence of hydrogen peroxide 
Table 5 ― Anticancer activity of Schiff base ligand and its % of 
cell inhibition at various concentrations 
Compound Concentration 
(µg/mL) 




Control 0 0.791 - 
1c 
100 14.34 
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Conclusions 
In our present work, the new eight complexes 
synthesised and derived isomeric form of two bis-
Schiff base ligands, namely N,N’-1,2-phenylenebis 
(methylidene))bis(4-hydroxybenzohydrazide) 1 and 
N,N’-1,3-phenylenebis(methylidene))bis(4-hydroxyb 
enzohydrazide) 2 are characterised by analytical and 
spectroscopic techniques. The analytical calculation 
and mass analyses confirmed the molecular formulae 
of complexes and assigned to coordination of metal 
with ligand in 1:1 molar ratio. The more binding 
interaction showed by ligand 1 due to position of 1, 
3 isomer. The metal complexes showed sustainable 
antimicrobial effects than the parent Schiff base 
ligand. The UV-visible absorbance titrations of 1c 
and 2c complexes results show that the non-covalent 
interaction is possible to intercalative mode of 
binding with ct-DNA. However, the complexes 1c 
and 2c posses effective cleavage and cleave double-
strands of PUC18DNA in the presence of hydroxyl 
radicals with increasing concentration. Antioxidant 
assay of DPPH radical activity revealed that all 
complexes gave the considerable potential effects. 
Cytotoxicity of complexes exhibited the valuable 
therapeutic properties against the MCF-7 cancerous 
cell line. 
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